نتایج جستجو برای: سالمند hdl c

تعداد نتایج: 1075686  

Journal: :Physiological genomics 2007
Nadine Spielmann Arthur S Leon D C Rao Treva Rice James S Skinner Claude Bouchard Tuomo Rankinen

Associations between cholesteryl ester transfer protein (CETP) polymorphisms and high-density lipoprotein cholesterol (HDL-c) levels before and after 20 wk of endurance training were investigated in the HERITAGE Family Study. Plasma HDL-c, HDL(2)-c, HDL(3)-c, and apolipoprotein (apo)A1 levels were measured, and 13 CETP single nucleotide polymorphisms (SNPs) were genotyped in 265 blacks and 486 ...

Journal: :American journal of physiology. Endocrinology and metabolism 2003
Karen L Herbst John K Amory John D Brunzell Howard A Chansky William J Bremner

Testosterone administration to men is known to decrease high-density lipoprotein cholesterol (HDL-C) and the subclasses HDL(2) and HDL(3). It also might increase the number of small, dense, low-density lipoprotein cholesterol (LDL-C) particles in hypogonadal men. The decrease in HDL-C and in LDL-C size is potentially mediated by hepatic lipase activity, which hydrolyzes lipoprotein phospholipid...

2010
Maria Luz Fernandez Jennifer J Jones Daniela Ackerman Jacqueline Barona Mariana Calle Michael V Comperatore Jung-Eun Kim Catherine Andersen Jose O Leite Jeff S Volek Mark McIntosh Colleen Kalynych Wadie Najm Robert H Lerman

Both metabolic syndrome (MetS) and elevated LDL cholesterol (LDL-C) increase the risk for cardiovascular disease (CVD). We hypothesized that low HDL cholesterol (HDL-C) would further increase CVD risk in women having both conditions. To assess this, we recruited 89 women with MetS (25-72 y) and LDL-C ≥ 2.6 mmol/L. To determine whether plasma HDL-C concentrations were associated with dietary com...

Fatemeh Bandarian, Fereidoun Azizi, Maryam Sadat Daneshpour, Mehdi Hedayati, Mohsen Naseri,

Background: Apolipoprotein A2 (APOA2) is the second major apolipoprotein of the high-density lipoprotein cholesterol (HDL-C). The study aim was to identify APOA2 gene variation in individuals within two extreme tails of HDL-C levels and its relationship with HDL-C level. Methods: This cross-sectional survey was conducted on participants from Tehran Glucose and Lipid Study (TLGS) at Research Ins...

Journal: :Clinical chemistry 2013
Norman A Mazer Franco Giulianini Nina P Paynter Paul Jordan Samia Mora

BACKGROUND HDL size and composition vary among individuals and may be associated with cardiovascular disease and diabetes. We investigated the theoretical relationship between HDL size and composition using an updated version of the spherical model of lipoprotein structure proposed by Shen et al. (Proc Natl Acad Sci U S A 1977;74:837-41.) and compared its predictions with experimental data from...

Journal: :Arquivos brasileiros de cardiologia 2009
Carlos Hermano da Justa Pinheiro Wilson Martins de Sousa Filho Joselito de Oliveira Neto Maria de Jesus Ferreira Marinho Renato Motta Neto Manuela Maria Ramos Lima Smith Carlos Antônio Bruno da Silva

BACKGROUND Chronically, glucocorticoids induce adverse cardiometabolic alterations including insulin resistance, diabetes, dyslipidemia, liver steatosis and arterial hypertension. OBJECTIVES To evaluate the effect of regular practice of aerobic exercise on cardiometabolic alterations induced by chronic administration of dexamethasone (Dex - 0.5 mg/kg/day ip) in rats. METHODS Male Wistar rat...

Journal: :Arteriosclerosis, thrombosis, and vascular biology 2015
Anandita P Agarwala Amrith Rodrigues Marjorie Risman Mary McCoy Kevin Trindade Liming Qu Marina Cuchel Jeffrey Billheimer Daniel J Rader

OBJECTIVE Plasma levels of high-density lipoprotein cholesterol (HDL-C) are strongly inversely associated with coronary artery disease (CAD), and high HDL-C is generally associated with reduced risk of CAD. Extremely high HDL-C with CAD is an unusual phenotype, and we hypothesized that the HDL in such individuals may have an altered composition and reduced function when compared with controls w...

2016
Yan-Yan Liu Shao-Jun Lin Yuan-Yuan Chen Li-Na Liu Liu-Bin Bao Lin-Quan Tang Jing-Song Ou Zhi-Gang Liu Xiao-Zhong Chen Yan Xu Jun Ma Anthony T. Chan Ming Chen Yun-Fei Xia Wan-Li Liu Yi-Xin Zeng Hai-Qiang Mai Mu-Sheng Zeng Jian-Ji Pan Xing Zhang

PURPOSE We aimed to assess the prognostic value of pretreatment high density lipoprotein cholesterol (HDL-C) levels in patients with nasopharyngeal carcinoma (NPC) and investigate the possible biological effects of these lipoproteins on NPC cells in vitro. EXPERIMENTAL DESIGN We examined the prognostic value of pretreatment HDL-C levels in 2443 patients with non-metastatic NPC from three inde...

Journal: :Atherosclerosis 2000
H A Schwertner J R Fischer

Studies were performed to determine if serum bilirubin, when combined with various lipid and lipoprotein risk factors, enhances our ability to predict coronary artery disease (CAD). This hypothesis was tested in a retrospective study of 644 middle-aged males who had undergone coronary angiography. The traditional risk factors of cholesterol, high density lipoprotein cholesterol (HDL-C), cholest...

Journal: :Diabetes care 2014
Boris Waldman Alicia J Jenkins Timothy M E Davis Marja-Riitta Taskinen Russell Scott Rachel L O'Connell Val J Gebski Martin K C Ng Anthony C Keech

OBJECTIVE Low HDL cholesterol (HDL-C) and small HDL particle size may directly promote hyperglycemia. We evaluated associations of HDL-C, apolipoprotein A-I (apoA-I), and HDL-C/apoA-I with insulin secretion, insulin resistance, HbA1c, and long-term glycemic deterioration, reflected by initiation of pharmacologic glucose control. RESEARCH DESIGN AND METHODS The 5-year Fenofibrate Intervention ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید